HRT Financial’s Edwards Lifesciences EW Stock Holding History

HRT Financial’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,800	Closed	-$409K	–	4059
2025 Q4	$409K	Buy	+4,800	New	+$394K	﹤0.01%	2215

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

HRT Financial's EW Position: Q2 2026 in Review

HRT Financial sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 34,242 shares — an estimated $2.74M sold.

HRT Financial first reported a position in EW in Q2 2019 and held it in 12 quarters. The position peaked at $19.7M in Q2 2019. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

HRT Financial reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 34,242 Edwards Lifesciences shares in Q2 2026, an estimated $2.74M.
HRT Financial first reported a position in Edwards Lifesciences in Q2 2019 and held it in 12 quarters.
HRT Financial's Edwards Lifesciences position peaked at $19.7M in Q2 2019.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.